Maravai Lifesciences Holdings Inc. (MAR)
XDUS
Closed
Aug 25, 2026
Day's Range
7.0052 wk Range
1.97Overview - MAR - Maravai Lifesciences Holdings Inc.
Key Statistics
Trading
Average Volume
25
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - MAR - Maravai Lifesciences Holdings Inc.
Peer Comparison
Compared with companies in Biotechnology listed on XDUS.
- MARXDUSMaravai Lifesciences Holdings Inc.+70.99%52-week change—P/E (Trailing)—Profit Margin
- 4E2XDUSRelmada Therapeutics Inc.+86.04%52-week change-2.59P/E (Trailing)—Profit Margin
- 3920XDUSSpyre Therapeutics, Inc.+84.40%52-week change-45.96P/E (Trailing)—Profit Margin
- 42ZXDUSRevolution Medicines Inc.+82.81%52-week change-30.12P/E (Trailing)—Profit Margin
- 87EXDUSDianthus Therapeutics Inc.+78.08%52-week change-22.38P/E (Trailing)—Profit Margin
- 5NRXDUSNanobiotix S.A.+77.54%52-week change—P/E (Trailing)—Profit Margin
- 5NRAXDUSNanobiotix S.A. American Depositary Shares+77.03%52-week change—P/E (Trailing)—Profit Margin
Profile Summary - MAR - Maravai Lifesciences Holdings Inc.
About
Maravai Lifesciences Holdings Inc. is a notable entity within the biotechnology and life sciences sector, primarily focused on providing critical products and services that advance scientific research and development. The company's main are the production of nucleic acids and biologics, which are essential components…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
